AbbVie Inc.
Hedge Funds Holdings
Last updated:
AbbVie Inc.‘s stocks are currently a part of 2932 hedge funds’ portfolios, which represents 66.51% of the total amount of its stocks outstanding. This makes up a total of 1.18B shares of AbbVie Inc.. Compared to the previous quarter, the number fell by -0.48% or -5.69M shares fewer. As for the holding position changes, 37.86% (1110) of current hedge fund investors increased the number of shares held, 43.66% (1280) of current holders sold a part of the shares held, and 4.5% (132) closed the holdings completely. 219 hedge funds are new holders of AbbVie Inc. stock in Q1 2022, it is 7.47% of total holders.
Hedge funds holding AbbVie (Q2 2017 – Q1 2022)
| Q2 2017 | 1,755 |
|---|---|
| Q3 2017 | 1,786 |
| Q4 2017 | 1,985 |
| Q1 2018 | 1,997 |
| Q2 2018 | 1,981 |
| Q3 2018 | 1,941 |
| Q4 2018 | 2,045 |
| Q1 2019 | 2,013 |
| Q2 2019 | 2,000 |
| Q3 2019 | 1,979 |
| Q4 2019 | 2,213 |
| Q1 2020 | 2,194 |
| Q2 2020 | 2,377 |
| Q3 2020 | 2,333 |
| Q4 2020 | 2,545 |
| Q1 2021 | 2,560 |
| Q2 2021 | 2,619 |
| Q3 2021 | 2,594 |
| Q4 2021 | 2,899 |
| Q1 2022 | 2,932 |
Hedge funds changes in AbbVie positions (Q2 2017 – Q1 2022)
| Q2 2017 | 129 | 644 | 721 | 70 | 191 |
|---|---|---|---|---|---|
| Q3 2017 | 123 | 586 | 821 | 71 | 185 |
| Q4 2017 | 276 | 579 | 895 | 61 | 174 |
| Q1 2018 | 142 | 645 | 995 | 101 | 114 |
| Q2 2018 | 86 | 810 | 823 | 87 | 175 |
| Q3 2018 | 75 | 739 | 863 | 105 | 159 |
| Q4 2018 | 221 | 679 | 883 | 109 | 153 |
| Q1 2019 | 127 | 783 | 885 | 136 | 82 |
| Q2 2019 | 131 | 894 | 750 | 122 | 103 |
| Q3 2019 | 127 | 849 | 782 | 133 | 88 |
| Q4 2019 | 323 | 820 | 821 | 69 | 180 |
| Q1 2020 | 155 | 990 | 823 | 142 | 84 |
| Q2 2020 | 265 | 1,261 | 663 | 66 | 122 |
| Q3 2020 | 114 | 1,054 | 888 | 137 | 140 |
| Q4 2020 | 341 | 1,095 | 852 | 99 | 158 |
| Q1 2021 | 146 | 1,254 | 883 | 106 | 171 |
| Q2 2021 | 150 | 1,257 | 890 | 75 | 247 |
| Q3 2021 | 110 | 1,316 | 855 | 104 | 209 |
| Q4 2021 | 420 | 1,267 | 893 | 92 | 227 |
| Q1 2022 | 219 | 1,110 | 1,280 | 132 | 191 |
Hedge funds changes in AbbVie stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 186,096,777,533 | 1,913,056,324 |
|---|---|---|
| Q3 2017 | 478,269,865,149 | 1,077,463,029 |
| Q4 2017 | 1,037,074,639 | 1,563,633,724 |
| Q1 2018 | 896,407,640 | 1,149,031,185 |
| Q2 2018 | 979,768,370 | 1,333,378,570 |
| Q3 2018 | 30,896,651,258 | 103,295,792,816 |
| Q4 2018 | 3,128,435,417 | 36,204,303,691 |
| Q1 2019 | 995,931,342 | 1,245,756,841 |
| Q2 2019 | 1,410,475,096 | 88,427,432,256 |
| Q3 2019 | 98,632,269,860 | 49,748,659,068 |
| Q4 2019 | 119,914,123,024 | 119,358,772,064 |
| Q1 2020 | 1,398,232,853 | 61,748,438,902 |
| Q2 2020 | 272,847,732,606 | 77,120,826,696 |
| Q3 2020 | 1,395,273,220 | 1,025,919,379,818 |
| Q4 2020 | 2,223,175,254 | 34,639,832,526 |
| Q1 2021 | 1,596,860,714 | 583,848,001,538 |
| Q2 2021 | 128,325,568,448 | 34,373,597,560 |
| Q3 2021 | 2,267,082,998 | 34,283,023,168 |
| Q4 2021 | 4,600,907,760 | 42,234,752,060 |
| Q1 2022 | 3,328,938,803 | 3,002,146,153 |